Press review
The essentials of recent medical publications, unpacked by our newsroom into a clear, sourced digest, specialty by specialty.
OphthalmologyMacrophage “clean-up crew” in the eye: a new lead against glaucoma
By Elodie Vaz | Published on March 13, 2026 | 3 min read Glaucoma is one of the leading causes of irreversible blindness worldwide. This condition encompasses a group of optic nerve disorders often associated with increased intraocular pressure. This pressure usually results from an imbalance between the production and drainage of aqueous humor, the fluid circulating inside the eye. Currently, man
OncologyGut microbiota and colorectal cancer: the cancer’s invisible ally?
By Ana Espino | Published on March 13, 2026 | 3 min readColorectal cancer (CRC) is among the most common and most lethal cancers worldwide. While established risk factors—diet, obesity, smoking, and physical inactivity—are well recognized, they do not fully explain tumor initiation and progression. Scientific attention has therefore increasingly turned to the intestinal microbiota, a central actor
GynecologyMpox and pregnancy: a risk for the fetus?
By Ana Espino | Published on March 12, 2026 | 3 min readMpox (formerly known as monkeypox) is a viral zoonosis caused by the Monkeypox virus (MPXV), a double-stranded DNA orthopoxvirus. Initially endemic in Central and West Africa, the virus experienced a major global expansion between 2022 and 2024, prompting the World Health Organization (WHO) to declare a public health emergency. More than 80,0
OncologyBreast cancer: shorter radiotherapy becomes the new global standard
By Elodie Vaz | Published on March 12, 2026 | 4 min read Breast cancer remains the most common cancer in women. In France, around 60,000 new cases are diagnosed each year, about one third of them at the locoregional stage. In these situations, treatment classically relies on surgery followed by radiotherapy targeting the breast or chest wall as well as the lymph node areas. Until recently, the ref
OncologyColorectal cancer: what if a blood test were enough?
By Ana Espino | Published on March 11, 2026 | 3 min readColorectal cancer (CRC) remains the third most common cancer worldwide, accounting for nearly 10% of all cancers. Despite the effectiveness of screening with fecal immunochemical tests and colonoscopy, diagnosis and monitoring still rely largely on invasive techniques that can be burdensome for patients. The transition toward precision oncolo
InfectiologyZika: A Latent Threat or a Past Danger?
By Ana Espino | Published on March 11, 2026 | 3 min readZika virus (ZIKV), an arbovirus primarily transmitted by Aedes aegypti, caused a major epidemic in Latin America between 2015 and 2018, with more than 500,000 reported cases and an unexpected rise in congenital malformations, particularly microcephaly. Since 2017, global incidence has declined. However, the virus remains endemic in 92 countri
OncologyColorectal cancer: mRNA nanobodies open a new avenue in immunotherapy
By Elodie Vaz | Published on March 11, 2026 | 3 min readColorectal cancer remains a major challenge in oncology. Immunotherapies targeting immune checkpoints have transformed the management of many tumors, but their effectiveness in this disease remains limited. Most patients present with so-called microsatellite-stable tumors, which are poorly responsive to treatments targeting the PD-1/PD-L1 imm
General MedicineAlgodystrophy: underestimated, under-recognized and undertreated conditions
By Elodie Vaz | Published on March 10, 2026 | 3 min read Long relegated to the status of a rare complication, complex regional pain syndrome (CRPS) remains a largely underestimated condition. Yet its consequences can be major. The disorder is characterized by persistent and disabling pain, most often affecting the limbs: wrist, shoulder, foot, or knee. It frequently occurs after trauma, a sprain,
OncologyColorectal cancer: why do treatments stop working?
By Ana Espino | Published on March 10, 2026 | 3 min readColorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide, despite major advances in surgery, chemotherapy, and targeted therapies. Improvements in diagnostic strategies and the introduction of modern therapeutic combinations have increased survival, particularly in metastatic disease. However, these gain
NeurologyPolylaminin and the return of voluntary motor contraction after complete spinal cord injury: a landmark pilot study
By Carolina Lima | Published on March 9, 2026 | 3 min readAcute spinal cord injury (SCI) remains one of the most complex and devastating conditions in medicine. Even with advances in emergency care, neurosurgery and rehabilitation, motor recovery in patients with complete SCI (AIS A) is extremely uncommon. Historical data consistently show that fewer than 15% of these individuals recover any degre
NeurosurgeryHigh-grade astrocytoma: combining two treatments opens a new therapeutic avenue
By Elodie Vaz | Published on March 9, 2026 | 3 min readHigh-grade astrocytoma, which includes glioblastoma, is among the most aggressive brain tumors. Its rapid growth and strong tendency to recur after surgical resection make it a disease with a poor prognosis. In the event of recurrence, median survival is generally only four to five months. While immune checkpoint inhibitors have transformed th
OncologyProstate cancer: focused ultrasound redefines the balance between oncologic control and functional preservation
By Elodie Vaz | Published on March 9, 2026 | 3 min read With nearly 60,000 new cases each year in France, prostate cancer is the most common cancer in men and the third leading cause of cancer-related mortality. One in six men over the age of 60 is affected. Although the prognosis of localized disease is often favorable, treatment remains associated, from the patient’s perspective, with feared fun